Literature DB >> 7857375

Hyperlipidaemia does not impair vascular endothelial function in glycogen storage disease type 1a.

P J Lee1, D S Celermajer, J Robinson, S N McCarthy, D J Betteridge, J V Leonard.   

Abstract

Patients with glycogen storage disease type 1 (GSD-1) often have marked hyperlipidaemia with abnormal lipoprotein profiles. This metabolic abnormality improves, but is not fully corrected, with dietary therapy and therefore these patients may be at high risk for the development of atherosclerosis. Endothelial dysfunction is an early event in atherogenesis and can be detected in children and young adults at high risk. We studied endothelial function, using a non-invasive ultrasonographic method, in the brachial arteries of 6 adult GSD-1a patients (aged 23-33 years) with mean cholesterol of 7.9 mmol/l (range 4.7 to 14.6) and mean triglycerides of 9.1 mmol/l (range 4.1 to 21.3), and 12 age- and sex-matched normolipidaemic controls. Flow-mediated (endothelium-dependent) dilation was similar in patients and controls (8.2% vs. 10.5%; P = 0.20). Although the patient numbers are small, these results are consistent with the surprising lack of clinically evident atherosclerosis in GSD-1. The reasons these patients appear less susceptible to the damaging arterial effects of hyperlipidaemia are unknown. These results may have implications for others with secondary hyperlipidaemias.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7857375     DOI: 10.1016/0021-9150(94)90072-8

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  10 in total

Review 1.  Dietary dilemmas in the management of glycogen storage disease type I.

Authors:  Kaustuv Bhattacharya
Journal:  J Inherit Metab Dis       Date:  2011-04-14       Impact factor: 4.982

2.  Apolipoprotein E polymorphism and serum concentrations in patients with glycogen storage disease type Ia.

Authors:  P Trioche; J Francoual; L Capel; M Odièvre; A Lindenbaum; P Labrune
Journal:  J Inherit Metab Dis       Date:  2000-03       Impact factor: 4.982

3.  Blood lipids and endothelial function in glycogen storage disease type III.

Authors:  E Hershkovitz; A Donald; M Mullen; P J Lee; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1999-12       Impact factor: 4.982

Review 4.  iPS cell modeling of cardiometabolic diseases.

Authors:  Kenta Nakamura; Ken-ichi Hirano; Sean M Wu
Journal:  J Cardiovasc Transl Res       Date:  2012-10-16       Impact factor: 4.132

5.  Vascular dysfunction in glycogen storage disease type I.

Authors:  Angelina V Bernier; Catherine E Correia; Michael J Haller; Douglas W Theriaque; Jonathan J Shuster; David A Weinstein
Journal:  J Pediatr       Date:  2008-12-21       Impact factor: 4.406

6.  Glycogen Storage Disease type 1a - a secondary cause for hyperlipidemia: report of five cases.

Authors:  Patrícia Margarida Serra Carvalho; Nuno José Marques Mendes Silva; Patrícia Glória Dinis Dias; João Filipe Cordeiro Porto; Lèlita Conceição Santos; José Manuel Nascimento Costa
Journal:  J Diabetes Metab Disord       Date:  2013-06-06

Review 7.  The hepatic glycogen storage diseases--problems beyond childhood.

Authors:  P J Lee; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

8.  Glycogen Storage Disease Type I (Von Gierke disease): Report of Two Cases with Severe Dyslipidemia.

Authors:  Julia Maria Avelino Ballavenuto; Jéssica D Ório Dantas de Oliveira; Renato Jorge Alves
Journal:  Arq Bras Cardiol       Date:  2020-05-18       Impact factor: 2.000

9.  Decreased plasma concentration of von Willebrand factor antigen (VWF:Ag) in patients with glycogen storage disease type Ia.

Authors:  C Mühlhausen; R Schneppenheim; U Budde; M Merkel; N Muschol; K Ullrich; R Santer
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.750

10.  Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia.

Authors:  N C den Hollander; D J Mulder; R Graaff; S R Thorpe; J W Baynes; G P A Smit; A J Smit
Journal:  J Inherit Metab Dis       Date:  2007-06-14       Impact factor: 4.982

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.